Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 358

1.

Structural basis for the discriminative recognition of N6-methyladenosine RNA by the human YT521-B homology domain family of proteins.

Xu C, Liu K, Ahmed H, Loppnau P, Schapira M, Min J.

J Biol Chem. 2015 Aug 28. pii: jbc.M115.680389. [Epub ahead of print]

PMID:
26318451
2.

Probing the epigenome.

Huston A, Arrowsmith CH, Knapp S, Schapira M.

Nat Chem Biol. 2015 Jul 21;11(8):542-5. doi: 10.1038/nchembio.1871. No abstract available.

PMID:
26196765
3.

The promise and peril of chemical probes.

Arrowsmith CH, Audia JE, Austin C, Baell J, Bennett J, Blagg J, Bountra C, Brennan PE, Brown PJ, Bunnage ME, Buser-Doepner C, Campbell RM, Carter AJ, Cohen P, Copeland RA, Cravatt B, Dahlin JL, Dhanak D, Edwards AM, Frye SV, Gray N, Grimshaw CE, Hepworth D, Howe T, Huber KV, Jin J, Knapp S, Kotz JD, Kruger RG, Lowe D, Mader MM, Marsden B, Mueller-Fahrnow A, Müller S, O'Hagan RC, Overington JP, Owen DR, Rosenberg SH, Roth B, Ross R, Schapira M, Schreiber SL, Shoichet B, Sundström M, Superti-Furga G, Taunton J, Toledo-Sherman L, Walpole C, Walters MA, Willson TM, Workman P, Young RN, Zuercher WJ.

Nat Chem Biol. 2015 Jul 21;11(8):536-41. doi: 10.1038/nchembio.1867. No abstract available.

PMID:
26196764
4.

Adherence to prompt fever evaluation in children with sickle cell disease and the health belief model.

Schultz CL, Tchume-Johnson T, Schapira MM, Bellamy S, Smith-Whitley K, Ellison A.

Pediatr Blood Cancer. 2015 Jul 14. doi: 10.1002/pbc.25634. [Epub ahead of print]

PMID:
26179160
5.

Pharmacological targeting of the Wdr5-MLL interaction in C/EBPα N-terminal leukemia.

Grebien F, Vedadi M, Getlik M, Giambruno R, Grover A, Avellino R, Skucha A, Vittori S, Kuznetsova E, Smil D, Barsyte-Lovejoy D, Li F, Poda G, Schapira M, Wu H, Dong A, Senisterra G, Stukalov A, Huber KV, Schönegger A, Marcellus R, Bilban M, Bock C, Brown PJ, Zuber J, Bennett KL, Al-Awar R, Delwel R, Nerlov C, Arrowsmith CH, Superti-Furga G.

Nat Chem Biol. 2015 Aug;11(8):571-8. doi: 10.1038/nchembio.1859. Epub 2015 Jul 13.

PMID:
26167872
6.

True "meaningful use": technology meets both patient and provider needs.

Black H, Gonzalez R, Priolo C, Schapira MM, Sonnad SS, Hanson CW, Langlotz CP, Howell JT, Apter AJ.

Am J Manag Care. 2015 May 1;21(5):e329-37.

7.

Provider Attitudes and Screening Practices Following Changes in Breast and Cervical Cancer Screening Guidelines.

Haas JS, Sprague BL, Klabunde CN, Tosteson AN, Chen JS, Bitton A, Beaber EF, Onega T, Kim JJ, MacLean CD, Harris K, Yamartino P, Howe K, Pearson L, Feldman S, Brawarsky P, Schapira MM; PROSPR (Population-based Research Optimizing Screening through Personalized Regimens) Consortium.

J Gen Intern Med. 2015 Jul 1. [Epub ahead of print]

PMID:
26129780
8.

Changes in written sign-out composition across hospitalization.

Miller DM, Schapira MM, Visotcky AM, Laud P, Arora VM, Kordus A, Whittle J, Singh S, Fletcher KE.

J Hosp Med. 2015 Aug;10(8):534-6. doi: 10.1002/jhm.2390. Epub 2015 Jun 9.

PMID:
26061434
9.

Implementation of an Advanced Practice Provider Service on an Allogeneic Stem Cell Transplant Unit: Impact on Patient Outcomes.

Shah NN, Kucharczuk CR, Mitra N, Hirsh R, Svoboda J, Porter D, Loren A, Frey N, Schapira MM.

Biol Blood Marrow Transplant. 2015 Sep;21(9):1692-8. doi: 10.1016/j.bbmt.2015.05.021. Epub 2015 May 29.

PMID:
26028503
10.

Do attitudes and beliefs regarding complementary and alternative medicine impact its use among patients with cancer? A cross-sectional survey.

Bauml JM, Chokshi S, Schapira MM, Im EO, Li SQ, Langer CJ, Ibrahim SA, Mao JJ.

Cancer. 2015 Jul 15;121(14):2431-8. doi: 10.1002/cncr.29173. Epub 2015 May 26.

PMID:
26011157
11.

Kinetic characterization of human histone H3 lysine 36 methyltransferases, ASH1L and SETD2.

Eram MS, Kuznetsova E, Li F, Lima-Fernandes E, Kennedy S, Chau I, Arrowsmith CH, Schapira M, Vedadi M.

Biochim Biophys Acta. 2015 Sep;1850(9):1842-8. doi: 10.1016/j.bbagen.2015.05.013. Epub 2015 May 19.

PMID:
26002201
12.

Structural diversity of the epigenetics pocketome.

Cabaye A, Nguyen KT, Liu L, Pande V, Schapira M.

Proteins. 2015 May 13. doi: 10.1002/prot.24830. [Epub ahead of print]

PMID:
25974248
13.

Unifying screening processes within the PROSPR consortium: a conceptual model for breast, cervical, and colorectal cancer screening.

Beaber EF, Kim JJ, Schapira MM, Tosteson AN, Zauber AG, Geiger AM, Kamineni A, Weaver DL, Tiro JA; Population-based Research Optimizing Screening through Personalized Regimens Consortium.

J Natl Cancer Inst. 2015 May 7;107(6):djv120. doi: 10.1093/jnci/djv120. Print 2015 Jun.

PMID:
25957378
14.

Discovery of a Dual PRMT5-PRMT7 Inhibitor.

Smil D, Eram MS, Li F, Kennedy S, Szewczyk MM, Brown PJ, Barsyte-Lovejoy D, Arrowsmith CH, Vedadi M, Schapira M.

ACS Med Chem Lett. 2015 Mar 2;6(4):408-12. doi: 10.1021/ml500467h. eCollection 2015 Apr 9.

PMID:
25893041
15.

A potent, selective and cell-active allosteric inhibitor of protein arginine methyltransferase 3 (PRMT3).

Kaniskan HÜ, Szewczyk MM, Yu Z, Eram MS, Yang X, Schmidt K, Luo X, Dai M, He F, Zang I, Lin Y, Kennedy S, Li F, Dobrovetsky E, Dong A, Smil D, Min SJ, Landon M, Lin-Jones J, Huang XP, Roth BL, Schapira M, Atadja P, Barsyte-Lovejoy D, Arrowsmith CH, Brown PJ, Zhao K, Jin J, Vedadi M.

Angew Chem Int Ed Engl. 2015 Apr 20;54(17):5166-70. doi: 10.1002/anie.201412154. Epub 2015 Feb 27.

PMID:
25728001
16.

Low Health Literacy Predicts Misperceptions of Diabetes Control in Patients With Persistently Elevated A1C.

Ferguson MO, Long JA, Zhu J, Small DS, Lawson B, Glick HA, Schapira MM.

Diabetes Educ. 2015 Jun;41(3):309-19. doi: 10.1177/0145721715572446. Epub 2015 Feb 19.

PMID:
25699568
17.

Public engagement with scientific evidence in health: A qualitative study among primary-care patients in an urban population.

Schapira MM, Imbert D, Oh E, Byhoff E, Shea JA.

Public Underst Sci. 2014 Dec 9. pii: 0963662514560489. [Epub ahead of print]

PMID:
25491359
18.

BAZ2A (TIP5) is involved in epigenetic alterations in prostate cancer and its overexpression predicts disease recurrence.

Gu L, Frommel SC, Oakes CC, Simon R, Grupp K, Gerig CY, Bär D, Robinson MD, Baer C, Weiss M, Gu Z, Schapira M, Kuner R, Sültmann H, Provenzano M; ICGC Project on Early Onset Prostate Cancer, Yaspo ML, Brors B, Korbel J, Schlomm T, Sauter G, Eils R, Plass C, Santoro R.

Nat Genet. 2015 Jan;47(1):22-30. doi: 10.1038/ng.3165. Epub 2014 Dec 8.

PMID:
25485837
19.

A global assessment of cancer genomic alterations in epigenetic mechanisms.

Shah MA, Denton EL, Arrowsmith CH, Lupien M, Schapira M.

Epigenetics Chromatin. 2014 Dec 4;7(1):29. doi: 10.1186/1756-8935-7-29. eCollection 2014.

20.

Development and validation of the numeracy understanding in Medicine Instrument short form.

Schapira MM, Walker CM, Miller T, Fletcher KE, Ganschow PS, Jacobs EA, Imbert D, O'Connell M, Neuner JM.

J Health Commun. 2014;19 Suppl 2:240-53. doi: 10.1080/10810730.2014.933916.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk